| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| T2286 | TCI | Trimethoprim | >98.0%(T)(HPLC) | 420元/25G; 990元/100G; 2990元/500G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C14H18N4O3 = 290.32 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 625127 | | PubChem物质ID | 87558288 | | Merck Index (14) | 9709 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 199.0 to 205.0 ℃ | | Solubility in hot Methanol | almost transparency |
物性(参考值) | 熔点 | 202 ℃ | | 水溶性 | 不溶 | | 在水中的溶解度 | 400 mg/l 25 ℃ | | 溶解性(微溶于) | 氯仿,甲醇 | | 溶解性(不溶于) | 苯,乙醚 |
相关法规 |
| 453948 | J&K | Trimethoprim | 98% | 154元/5G; 613元/25G; | 展开 |
基本信息 | 分子式 | C14H18N4O3 | | 分子量 | 290.32 | | 熔点 | 199-205 | | MDL编码 | MFCD00036761 | | Beilstein | 625127 | | Merck | 14,9709 | | EINECS 编号 | 212-006-2 | | 存储条件 | Store at 2-8℃ | 一般描述 化学结构:嘧啶 应用 甲氧苄啶是最主要的抗细菌剂。 它有二氢叶酸还原酶抑制活性和原核酶选择性。 它被用来治疗尿道感染,轻度急性前列腺炎,复发性膀胱炎,怀孕期间无症状菌尿和呼吸道感染。主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 生化/生理作用 甲氧苄啶和磺胺甲恶唑结合,通过阻碍核苷酸合成,干扰细菌细胞叶酸细胞代谢。 甲氧苄啶和二氢叶酸还原酶结合,抑制二氢叶酸(DHF)和四氢叶酸(THF)还原。THF是胸腺嘧啶合成途径基本前体,干扰该途径,抑制细菌DNA合成。 其他说明 保持容器密闭,置于干燥通风处。置于干燥处。 安全信息 | 防范说明 | P262 | | WGK | 3 | | RTECS | UV8225000 |
|
| J63053 | Alfa Aesar | Trimethoprim | | 333元/1g; 1334元/5g; 3320元/25g; | 展开 |
应用 An antibacterial and inhibitor of formylation. Dihydrofolate reductase inhibitor with selectivity for the prokaryote enzyme.Trimethoprim is an antibiotic involved in the treatment of urinary tract infections, middle ear infections and traveler?’s diarrhea. It is associated with sulfamethoxazole and interferes with the cellular metabolism of folic acid in the bacterial cell by blocking the biosynthesis of nucleotides. Furthermore, It is also used to treat and prevent Pneumocystis jiroveci pneumonia. 备注 Sensitive to light. Incompatible with strong oxidizing agents. Sore in a cool place. 基本信息 MDL MFCD00036761 EINECS 212-006-2 分子式 C14H18N4O3 分子量 290.32 熔点 199-203° 灵敏度 Keep Cold. 形态 Powder 溶解性 Trimethoprim is soluble in water at 0.4 mg/ml. It is also soluble in DMSO at 50 mg/ml and chloroform at 18.2 mg/ml. Soluble in methanol, chloroform, dimethyl sulfoxide, N,N-dimethylacetamide, benzyl alcohol, and propylene glycol. Insoluble in water, diethyl ether and benzene. Beilstein 625127 Merck 14,9709 安全信息 RTECS UV8225000 TSCA 否 |
| R10838 | Alfa Aesar | Trimethoprim Standard solution | 100ppm | 335元/1ml; | 展开 |
|
| R11925 | Alfa Aesar | Trimethoprim,1000ppm | | 704元/1ml; | 展开 |
|
| Y0000684 | | Trimethoprim for system suitability | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 包装 Unit quantity: 0.001 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 329831095 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| T7883 | Sigma-Aldrich | Trimethoprim | ≥98.5% | 1742.3元/5 g; 6684.71元/25 g; 14390.2元/100 g; | 展开 |
产品说明 一般描述 化学结构:嘧啶 应用 甲氧苄啶是最主要的抗细菌剂。 它有二氢叶酸还原酶抑制活性和原核酶选择性。 它被用来治疗尿道感染,轻度急性前列腺炎,复发性膀胱炎,怀孕期间无症状菌尿和呼吸道感染。 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 生化/生理作用 甲氧苄啶和磺胺甲恶唑结合,通过阻碍核苷酸合成,干扰细菌细胞叶酸细胞代谢。 甲氧苄啶和二氢叶酸还原酶结合,抑制二氢叶酸(DHF)和四氢叶酸(THF)还原。THF是胸腺嘧啶合成途径基本前体,干扰该途径,抑制细菌DNA合成。 包装 5G,25G,100G 其他说明 保持容器密闭,置于干燥通风处。置于干燥处。 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | EC 号 | 212-006-2 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 24278201 | | NACRES | NA.85 |
产品性质 | 质量水平 | 200 | | 测定 | ≥98% (HPLC) | | 形式 | powder | | 储存条件 | (Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.) | | 颜色 | white to off-white | | 溶解性 | chloroform/ethanol (1:1): soluble 50 mg/mL DMSO: soluble | | 作用机制 | DNA synthesis | interferes enzyme | inhibits | | 抗生素抗菌谱 | Gram-negative bacteria Gram-positive bacteria mycobacteria | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N | | Gene Information | human ... DHFRP1(573971), KCNH1(3756) rat ... Dhfr(24312) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| 92131 | Sigma-Aldrich | Trimethoprim | ≥99.0% (HPLC) | 603.83元/1 g; 1782.29元/5 g; 6997.08元/25 g; | 展开 |
产品说明 一般描述 化学结构:嘧啶 应用 甲氧苄啶主要用作抗菌剂。用于结核分枝杆菌的敏感性研究和流感嗜血杆菌的耐药性研究。 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 生化/生理作用 甲氧苄啶是一种二氢叶酸还原酶抑制剂,对原核生物酶具有选择性。 通过原核生物特异的二氢叶酸还原酶(DHFR)抑制四氢叶酸的合成。 包装 1g、5g、25g 其他说明 将容器密闭保存在干燥通风的地方。对光敏感。在惰性气体下储存。对水分敏感。产品对光和水分敏感。 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | EC 号 | 212-006-2 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 57653467 | | NACRES | NA.85 |
产品性质 | 质量水平 | 200 | | 生物来源 | synthetic | | 测定 | ≥99.0% (HPLC) | | 形式 | powder | | 质量 | crystallized | | 颜色 | white to yellow | | mp | 199-203 ℃ | | 作用机制 | DNA synthesis | interferes enzyme | inhibits | | 抗生素抗菌谱 | Gram-negative bacteria Gram-positive bacteria mycobacteria | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N | | Gene Information | human ... DHFRP1(573971), KCNH1(3756) rat ... Dhfr(24312) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| 46984 | Supelco | Trimethoprim | VETRANAL®, analytical standard | 761.09元/250 MG; | 展开 |
产品说明 一般描述 化学结构:嘧啶 应用 有关合适仪器技术的更多信息,请参考产品分析证书。如需进一步支持,请联系技术服务。 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 法律信息 VETRANAL is a registered trademark of sigma-aldrich Chemie GmbH 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | EC 号 | 212-006-2 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 329757283 | | NACRES | NA.24 |
产品性质 | 质量水平 | 100 | | 等级 | analytical standard | | agency | EPA 1694 | | 产品线 | VETRANAL® | | 保质期 | limited shelf life, expiry date on the label | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | 抗生素抗菌谱 | Gram-negative bacteria Gram-positive bacteria mycoplasma | | application(s) | clinical testing | | 格式 | neat | | 作用机制 | DNA synthesis | interferes enzyme | inhibits | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| PHR1056 | Supelco | Trimethoprim | Pharmaceutical Secondary Standard; Certified Reference Material | 1359.83元/1 G; | 展开 |
产品说明 一般描述 用于质量控制的已认证的药物二级标准,为制药实验室和制造商提供了药典基本标准的一种方便且成本效益好的替代品。甲氧苄啶是一种合成的抗菌剂,对大多数需氧革兰氏阴性和革兰氏阳性细菌具有体外抗菌活性。它的作用方式涉及到抑制二氢叶酸还原酶,这是一种可在微生物和真核细胞中催化将二氢叶酸还原为四氢叶酸的酶。 应用 甲氧苄啶可作为药物参考标准品,通过色谱以及可见光和紫外分光光度技术对药物制剂中的分析物进行测定。 这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 分析说明 这些二级标准品可追溯至USP、EP(PhEur)和BP一级标准品。 其他说明 该认证参考物质 (CRM) 按照 ISO 17034 和 ISO/IEC 17025 生产和认证。所有关于此 CRM 的信息均记载在分析证书中。 附注 要查看该材料的分析证书示例,请在下面的栏位中输入 LRAA7172。这只是一个示例证书,可能不是您收到的批次。 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | EC 号 | 212-006-2 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 329823086 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 344 traceable to PhEur T220000 traceable to USP 1692505 | | 储存温度 | 2-30℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| T2200000 | | Trimethoprim | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 329826703 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 16967 | Supelco | Trimethoprim | certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland | 1755.66元/100 mg; | 展开 |
产品说明 一般描述 该有证标准物质(CRM)是根据ISO/IEC 17025和ISO 17034生产和认证的。该CRM可追溯到来自NMI的原材料,如 NIST或NMIJ。 证书上给出了定量核磁共振法认证的内容,包括不确定性和失效日期。 请访问http://www.sigma-aldrich.com下载您的证书。 应用 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 法律信息 TraceCERT is a registered trademark of sigma-aldrich Co. LLC 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | EC 号 | 212-006-2 | | MDL编号 | MFCD00036761 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material TraceCERT® | | 产品线 | TraceCERT® | | 保质期 | limited shelf life, expiry date on the label | | technique(s) | gas chromatography (GC): suitable | | application(s) | forensics and toxicology pharmaceutical (small molecule) | | 格式 | neat | | 运输 | wet ice | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP344 | | Trimethoprim | British Pharmacopoeia (BP) Reference Standard | 1952.55元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | EC 号 | 212-006-2 | | MDL编号 | MFCD00036761 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1692505 | USP | Trimethoprim | United States Pharmacopeia (USP) Reference Standard | 3231.47元/300 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主要作为抗细菌剂。 二氢叶酸还原酶抑制活性和原核酶选择性。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H18N4O3 | | 分子量 | 290.32 | | Beilstein | 625127 | | MDL编号 | MFCD00036761 | | PubChem化学物质编号 | 329751414 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | 危险分类 | Acute Tox. 3 Oral - Repr. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|